Back to the main directory
Company Analysis / Equity
- Accor's intangible asset advantage intact, despite weakened new businesses segment. by Morningstar
- Morningstar | Chipotle's Growth Plans Encouraging, but Lofty Market Expectations Leave Little Room for Error by Morningstar
- Morningstar | Grifols' 2Q Looks Steady as Firm Dips Toes Into China Plasma Collection by Morningstar
- Morningstar | Accor's intangible asset advantage intact, despite weakened new businesses segment. by Morningstar
- Morningstar | Valero Energy Partners is an MLP operating logistics assets supporting its refining sponsor. by Morningstar
- Europac: 1H18 results comment by Bankinter S.A.
- Continued Decline in 2Q for Oil and Gas E&Cs, but Outlook Remains More Positive by Morningstar
- Morningstar | North American short-line railroad deals are Genesee & Wyoming's specialty. by Morningstar
- Genuine Parts should benefit as more seasonable winter weather leads to increased auto-parts sales. by Morningstar
- Morningstar | Continued Decline in 2Q for Oil and Gas E&Cs, but Outlook Remains More Positive by Morningstar
- Morningstar | Continued Decline in 2Q for Oil and Gas E&Cs, but Outlook Remains More Positive by Morningstar
- Morningstar | LifePoint 2Q Results a Nonevent; Takeout Set to Close in Coming Months by Morningstar
- Morningstar | Genuine Parts should benefit as more seasonable winter weather leads to increased auto-parts sales. by Morningstar
- Morningstar | Buoyed by Hepatitis C Drug Gains, AbbVie Posts Strong 2Q; Stock Looks Modestly Undervalued by Morningstar
- Morningstar | Autoliv Posts Solid 2Q Results but Lowers 2018 Guidance; $80 Fair Value Unchanged by Morningstar
- Morningstar | D.R. Horton Has Another Great Quarter; Gross Margin Trending Toward High End of Guidance; FVE to $46 by Morningstar
- Dr. Reddy's Fiscal 1Q Performance Boosted by Generics Business by Morningstar
- Sonic's Second Quarter Not a Surprise Given July 17 Guidance Cut but EchoPark Turning a Corner by Morningstar
- Tenneco 2Q Disappoints Slightly, but Stock Remains Attractively Valued; $73 FVE Unchanged by Morningstar
- Morningstar | Dr. Reddy's Fiscal 1Q Performance Boosted by Generics Business by Morningstar
- Morningstar | Dr. Reddy's Fiscal 1Q Performance Boosted by Generics Business by Morningstar
- Weyerhaeuser's profits will surge with rising housing starts and diminished Canadian competition. by Morningstar
- Morningstar | Weyerhaeuser's profits will surge with rising housing starts and diminished Canadian competition. by Morningstar
- Morningstar | Zimmer Biomet Sees Improved Growth in 2Q; No Change to Our FVE by Morningstar
- Morningstar | Higher Costs, Foreign Exchange Taint Colgate's Full-Year Profit Outlook, but Wide Moat Unwavering by Morningstar
- Grifols' 2Q Looks Steady as Firm Dips Toes Into China Plasma Collection by Morningstar
- Morningstar | Grifols' 2Q Looks Steady as Firm Dips Toes Into China Plasma Collection by Morningstar
- Morningstar | 2Q Earnings Disappoint, but Exxon Remains a Long-Term Story by Morningstar
- Continued Decline in 2Q for Oil and Gas E&Cs, but Outlook Remains More Positive by Morningstar
- Rovi: 1H18 results comment by Bankinter S.A.
- Raising EPS Estimates; 2Q EPS Up 16% on 8.5% Organic Growth by Great Lakes Review, a division of Wellington Shields & Co. LLC
- Weekly Market Wrap - 27 July 2018 by Vetiva Capital Management
- Morningstar | Genesee & Wyoming Sees Solid 2Q Improvement in North American Carloads by Morningstar
- LifePoint 2Q Results a Nonevent; Takeout Set to Close in Coming Months by Morningstar
- Morningstar | Continued Decline in 2Q for Oil and Gas E&Cs, but Outlook Remains More Positive by Morningstar
- Morningstar | Continued Decline in 2Q for Oil and Gas E&Cs, but Outlook Remains More Positive by Morningstar
- D.R. Horton Has Another Great Quarter; Gross Margin Trending Toward High End of Guidance; FVE to $46 by Morningstar
- PG&E Far From Resolving Wildfire Issues, but Core Business Still Strong by Morningstar
- Buoyed by Hepatitis C Drug Gains, AbbVie Posts Strong 2Q; Stock Looks Modestly Undervalued by Morningstar
- Morningstar | D.R. Horton Has Another Great Quarter; Gross Margin Trending Toward High End of Guidance; FVE to $46. See Updated Analyst Note from 27 Jul 2018 by Morningstar
- Morningstar | PG&E Far From Resolving Wildfire Issues, but Core Business Still Strong by Morningstar
- Morningstar | Sonic's Second Quarter Not a Surprise Given July 17 Guidance Cut but EchoPark Turning a Corner by Morningstar
- Morningstar | Tenneco 2Q Disappoints Slightly, but Stock Remains Attractively Valued; $73 FVE Unchanged by Morningstar
- Morningstar | Icon's 2Q Performance Largely Tracks Our Expectations by Morningstar
- Morningstar | Dr. Reddy's Fiscal 1Q Performance Boosted by Generics Business by Morningstar
- Morningstar | We expect management to turn to acquisitions to enhance West's already-wide economic moat. by Morningstar
- Higher Costs, Foreign Exchange Taint Colgate's Full-Year Profit Outlook, but Wide Moat Unwavering by Morningstar
- Morningstar | Weyerhaeuser's Performs Well in 2Q on Robust Wood Product Results by Morningstar
- Morningstar | Despite Labor Strikes Bradesco's Loan Growth and Credit Quality Improves in 2Q by Morningstar
- Yamana Shares Rally After a Strong 2Q, but Shares Look Fairly Valued by Morningstar